These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 16787662)
1. The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experience. Menes M; Vakiani E; Keller CE; Ho EK; Colovai A; Nichols G; Diuguid D; Mears JG; Murty VV; Alobeid B; Bhagat G Leuk Res; 2007 Jan; 31(1):59-65. PubMed ID: 16787662 [TBL] [Abstract][Full Text] [Related]
2. [Evolutive epidemiologic profile of myelodysplastic syndromes (1959-1993). Comparative study with acute myeloid leukemia and aplastic pancytopenias]. Sánchez Fayos J; Outeiriño Pérez JJ; Prieto E; Román A; Olavarría E; Cabello A; Soto C; Calabuig T; Paniagua C; Sanz B Sangre (Barc); 1994 Dec; 39(6):441-8. PubMed ID: 7855696 [TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714 [TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
5. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature. Swolin B; Rödjer S; Westin J Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056 [TBL] [Abstract][Full Text] [Related]
9. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? Hake CR; Graubert TA; Fenske TS Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301 [TBL] [Abstract][Full Text] [Related]
10. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Singh ZN; Huo D; Anastasi J; Smith SM; Karrison T; Le Beau MM; Larson RA; Vardiman JW Am J Clin Pathol; 2007 Feb; 127(2):197-205. PubMed ID: 17210514 [TBL] [Abstract][Full Text] [Related]
11. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies. Reddy VV Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998 [TBL] [Abstract][Full Text] [Related]
12. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia. Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727 [TBL] [Abstract][Full Text] [Related]
13. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192 [TBL] [Abstract][Full Text] [Related]
14. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes. Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964 [TBL] [Abstract][Full Text] [Related]
15. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911 [TBL] [Abstract][Full Text] [Related]
16. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866 [TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes: more prevalent than we know. Sandhu SK; Sekeres MA Geriatrics; 2008 Nov; 63(11):10-7. PubMed ID: 18998762 [TBL] [Abstract][Full Text] [Related]
19. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Offman J; Opelz G; Doehler B; Cummins D; Halil O; Banner NR; Burke MM; Sullivan D; Macpherson P; Karran P Blood; 2004 Aug; 104(3):822-8. PubMed ID: 15090454 [TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes: incidence and survival in the United States. Ma X; Does M; Raza A; Mayne ST Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]